<DOC>
	<DOC>NCT01770067</DOC>
	<brief_summary>Following previous positive experience with CITA-RNPT of infected pacemakers, we suggest that CITA-RNPT can be administered prophylactically to patients prior to replacement of CIED, immun-compromised patients, and others.</brief_summary>
	<brief_title>Prophylactic Treatment of High-Risk Patients With Cardiovascular Implantable Electronic Devices (CIED)With Continuous In-Situ Ultra High-Dose Antibiotics (CITA) Under Regulated Negative Pressure-Assisted Wound Therapy (RNPT)</brief_title>
	<detailed_description />
	<criteria>Highrisk patients for CIED infections All others</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Cardiac Resynchronization Therapy Devices</keyword>
</DOC>